Nivolumab in mRCC Patients: Treg Function, T-cell Access and NK Interactions to Predict and Improve Efficacy
Clinical trial NCT03891485 · COMPLETED
Trial details
- NCT number
- NCT03891485
- Sponsor
- National Cancer Institute, Naples
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-12-01
- Primary completion
- 2022-09-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.